EPFL spinout MindMaze has raised $105m from investors including AlbaCore Capital, which had supplied $125m in capital only four months ago.

MindMaze, a Switzerland-based digital neurotherapeutics platform spun out of EPFL, received $105m in a funding round on Thursday led by private equity firm Concord Health Partners. The round also featured AlbaCore Capital, Hambro Perks and several unnamed family offices. Although an updated valuation was not disclosed, MindMaze is worth at least $1.5bn. Founded in 2012,…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.